Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 4Dermatologic 4Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Leukemia, Lymphocytic, Chronic, B-Cell 215Lymphoma, Non-Hodgkin 204Lymphoma, Follicular 193Lymphoma, Large B-Cell, Diffuse 180Leukemia 164Hodgkin Disease 160Multiple Myeloma 118Neoplasms 97Leukemia, Myeloid, Acute 87Lymphoma, Mantle-Cell 78Burkitt Lymphoma 67Myelodysplastic Syndromes 64Lymphoma, B-Cell, Marginal Zone 64Lymphoma, T-Cell, Cutaneous 62Breast Neoplasms 62Mycosis Fungoides 55Recurrence 52Lymphoma, B-Cell 50Hematologic Neoplasms 50Sezary Syndrome 43Waldenstrom Macroglobulinemia 41Myeloproliferative Disorders 39Neoplasms, Plasma Cell 38Lung Neoplasms 34Lymphoma, Large-Cell, Immunoblastic 33Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 32Lymphoma, T-Cell, Peripheral 29Leukemia, Hairy Cell 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Mastocytosis, Cutaneous × Lymphoid × Clear all
NCT02620254 2021-02-04

Mast Cell Connect: A Registry for Patients With Mastocytosis

Blueprint Medicines Corporation

Completed
743 enrolled
DermatologicLymphoidMyeloidOther hematologic neoplasm

Telangiectasia macularis eruptiva perstans, Leukemia, Mast-Cell, Mastocytosis, Urticaria Pigmentosa, Mastocytosis, Cutaneous, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡